ReP USP - Resultado da busca

Tese (Doutorado)
Eletrorretinograma de padrão reverso macular e multifocal e tomografia de coerência óptica em olhos suspeitos de glaucoma e glaucomatosos com perda de hemicampo (2016)
Kreuz, André Carvalho; Monteiro, Mario Luiz Ribeiro (Orientador)
Unidade: FM
Subjects: ELETRORRETINOGRAFIA (MÉTODOS), GLAUCOMA (CONGÊNITO;DIAGNÓSTICO), HIPERTENSÃO OCULAR (TERAPIA), VISÃO (ANORMALIDADES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KREUZ, André Carvalho. Eletrorretinograma de padrão reverso macular e multifocal e tomografia de coerência óptica em olhos suspeitos de glaucoma e glaucomatosos com perda de hemicampo. 2016. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2016. Disponível em: http://www.teses.usp.br/teses/disponiveis/5/5149/tde-06022017-110458/. Acesso em: 01 jun. 2024.
APA
Kreuz, A. C. (2016). Eletrorretinograma de padrão reverso macular e multifocal e tomografia de coerência óptica em olhos suspeitos de glaucoma e glaucomatosos com perda de hemicampo (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/5/5149/tde-06022017-110458/
NLM
Kreuz AC. Eletrorretinograma de padrão reverso macular e multifocal e tomografia de coerência óptica em olhos suspeitos de glaucoma e glaucomatosos com perda de hemicampo [Internet]. 2016 ;[citado 2024 jun. 01 ] Available from: http://www.teses.usp.br/teses/disponiveis/5/5149/tde-06022017-110458/
Vancouver
Kreuz AC. Eletrorretinograma de padrão reverso macular e multifocal e tomografia de coerência óptica em olhos suspeitos de glaucoma e glaucomatosos com perda de hemicampo [Internet]. 2016 ;[citado 2024 jun. 01 ] Available from: http://www.teses.usp.br/teses/disponiveis/5/5149/tde-06022017-110458/
Artigo de periodico
Additive Intraocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% (Cosopt) on Monotherapy With Latanoprost (Xalatan) in Patients With Elevated Intraocular Pressure: A Prospective, 4-week, Open-label, Randomized, Controlled Clinical Trial (2010)
Hatanaka, Marcelo; Reis, Alexandre; Sano, Milena Eimi; SusannaJr., Remo
Source: Journal of Glaucoma. Unidade: FM
Subjects: GLAUCOMA, TERAPIA COMBIANADA, HIPERTENSÃO OCULAR (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HATANAKA, Marcelo et al. Additive Intraocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% (Cosopt) on Monotherapy With Latanoprost (Xalatan) in Patients With Elevated Intraocular Pressure: A Prospective, 4-week, Open-label, Randomized, Controlled Clinical Trial. Journal of Glaucoma, v. 19, n. 5, p. 331-335, 2010Tradução . . Disponível em: https://doi.org/10.1097/IJG.0b013e3181b4cab4. Acesso em: 01 jun. 2024.
APA
Hatanaka, M., Reis, A., Sano, M. E., & SusannaJr., R. (2010). Additive Intraocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% (Cosopt) on Monotherapy With Latanoprost (Xalatan) in Patients With Elevated Intraocular Pressure: A Prospective, 4-week, Open-label, Randomized, Controlled Clinical Trial. Journal of Glaucoma, 19( 5), 331-335. doi:10.1097/IJG.0b013e3181b4cab4
NLM
Hatanaka M, Reis A, Sano ME, SusannaJr. R. Additive Intraocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% (Cosopt) on Monotherapy With Latanoprost (Xalatan) in Patients With Elevated Intraocular Pressure: A Prospective, 4-week, Open-label, Randomized, Controlled Clinical Trial [Internet]. Journal of Glaucoma. 2010 ; 19( 5): 331-335.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1097/IJG.0b013e3181b4cab4
Vancouver
Hatanaka M, Reis A, Sano ME, SusannaJr. R. Additive Intraocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% (Cosopt) on Monotherapy With Latanoprost (Xalatan) in Patients With Elevated Intraocular Pressure: A Prospective, 4-week, Open-label, Randomized, Controlled Clinical Trial [Internet]. Journal of Glaucoma. 2010 ; 19( 5): 331-335.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1097/IJG.0b013e3181b4cab4
Artigo de periodico
An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure (2008)
Hatanaka, Marcelo; Grigera, Daniel E; Barbosa, Wilma L; Jordão, Marcelo; Susanna Júnior, Remo
Source: journal of glaucoma. Unidade: FM
Subjects: GLAUCOMA (TERAPIA), HIPERTENSÃO OCULAR (TERAPIA), SEGUIMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HATANAKA, Marcelo et al. An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma, v. 17, n. 8, p. 674-679, 2008Tradução . . Acesso em: 01 jun. 2024.
APA
Hatanaka, M., Grigera, D. E., Barbosa, W. L., Jordão, M., & Susanna Júnior, R. (2008). An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma, 17( 8), 674-679.
NLM
Hatanaka M, Grigera DE, Barbosa WL, Jordão M, Susanna Júnior R. An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma. 2008 ; 17( 8): 674-679.[citado 2024 jun. 01 ]
Vancouver
Hatanaka M, Grigera DE, Barbosa WL, Jordão M, Susanna Júnior R. An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma. 2008 ; 17( 8): 674-679.[citado 2024 jun. 01 ]

USP Schools

ReP

Filtros

Authors

Subjects